US 10494435
Human monoclonal antibodies specific for CD22
granted A61KA61K2039/505A61K38/164
Quick answer
US patent 10494435 (Human monoclonal antibodies specific for CD22) held by The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services expires Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services
- Grant date
- Tue Dec 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2039/505, A61K38/164, A61K38/45, A61K39/00